chr12-104215848-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001093771.3(TXNRD1):āc.46G>Cā(p.Glu16Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000628 in 1,560,756 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001093771.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TXNRD1 | NM_001093771.3 | c.46G>C | p.Glu16Gln | missense_variant | 1/17 | ENST00000525566.6 | NP_001087240.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TXNRD1 | ENST00000525566.6 | c.46G>C | p.Glu16Gln | missense_variant | 1/17 | 1 | NM_001093771.3 | ENSP00000434516.1 |
Frequencies
GnomAD3 genomes AF: 0.000282 AC: 43AN: 152240Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000510 AC: 8AN: 156792Hom.: 0 AF XY: 0.0000235 AC XY: 2AN XY: 85022
GnomAD4 exome AF: 0.0000362 AC: 51AN: 1408398Hom.: 0 Cov.: 31 AF XY: 0.0000287 AC XY: 20AN XY: 695840
GnomAD4 genome AF: 0.000308 AC: 47AN: 152358Hom.: 1 Cov.: 33 AF XY: 0.000255 AC XY: 19AN XY: 74506
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 02, 2024 | The c.46G>C (p.E16Q) alteration is located in exon 1 (coding exon 1) of the TXNRD1 gene. This alteration results from a G to C substitution at nucleotide position 46, causing the glutamic acid (E) at amino acid position 16 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at